Author(s)

Matthew Witek, Yelena Vahknenko, Joshua Siglin, Amy Harrison, Ying Xiao, Haison Lui, David Andrews, Wenyin Shi

Department of Neurosurgery, Thomas Jefferson University Hospital, Philadelphia, USA.
Department of Radiation Oncology, Thomas Jefferson University Hospital, Philadelphia, USA.

We evaluated the feasibility of combined hippocampal- and scalp-sparing intensity-modulated radiotherapy (IMRT) plans. This study included 7 patients who received conventional palliative whole brain radiation treatment (WBRT) for brain metastasis. The brain, hippocampus, and scalp were contoured and replanned with intensity modulated radiation therapy. The prescription dose was 30 Gray (Gy) in 10 fractions with hippocampus and normal structure constraints per the Radiation Therapy Oncology Group (RTOG) 0933 protocol. Further planning was done to minimize the scalp dose while maintaining the dose constraints for the hippocampus. Dose volume histograms were obtained from conventional opposed lateral fields, IMRT and compared. Planning target volume (PTV) coverage for all plans fell within the RTOG 0933 critical structure acceptable variation category. When compared to traditional opposed lateral fields, the IMRT plan with combined hippocampal- and scalp-sparing constraints was able to significantly reduce the max and mean scalp dose as well as the percentage of scalp receiving 10 and 20 Gy by 46% and 35%, respectively, while maintaining acceptable RTOG 0933 hippocampal dose variations. We conclude that acceptable PTV coverage and sparing of the scalp and hippocampus can be accomplished using a 9-field non-coplanar IMRT plan. Prospective study is warranted to understand the impact on radiation-induced alopecia.

Hippocampal, Scalp Sparing WBRT, IMRT

Witek, M. , Vahknenko, Y. , Siglin, J. , Harrison, A. , Xiao, Y. , Lui, H. , Andrews, D. and Shi, W. (2014) Dose Reduction to the Scalp with Hippocampal Sparing Is Achievable with Intensity Modulated Radiotherapy. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, 3, 176-182. doi: 10.4236/ijmpcero.2014.33023.